THE DEVELOPMENT OF AN ORAL ENZYMATIC THERAPY ADJUNCTIVE TO THE DIETARY MANAGEMENT OF CELIAC DISEASE

$4,239,889FY2024Defense Health AgencyDOD

Enteralia Bioscience Llc

Investigators